Cardio Diagnostics Holdings, Inc.
CDIONASDAQHealthcare● Active
$1.99
+$0.03(+1.53%)
Market Cap$4120544
P/E Ratio—
52W High$7.91
52W Low$0.97
Cardio Diagnostics Holdings, Inc. (CDIO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDIO · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.63
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
🔥 7-Quarter EPS Beat Streak
CDIO reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 15, 2026 | — | -$0.63 | — | $0.00B | — | — |
| ▲ Q1 FY2026 | Mar 13, 2026 | -$1.80 | -$0.80 | +55.6% | $0.00B | $0.00B | -98.6% |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$1.80 | -$0.98 | +45.6% | $0.00B | $0.00B | -98.1% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$1.80 | -$0.97 | +46.1% | $0.00B | $0.00B | -90.0% |
| ▲ Q2 FY2025 | May 15, 2025 | -$1.80 | -$0.97 | +46.1% | $0.00B | $0.00B | -98.8% |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$0.06 | -$0.01 | +83.3% | $0.00B | $0.00B | -82.0% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.15 | -$0.06 | +60.0% | $0.00B | $0.00B | -73.7% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026
EPS Actual
-$0.63
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Mar 13, 2026Beat
EPS Actual
-$0.80
EPS Est.
-$1.80
EPS Surpr.
+55.6%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$0.98
EPS Est.
-$1.80
EPS Surpr.
+45.6%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.97
EPS Est.
-$1.80
EPS Surpr.
+46.1%
Revenue
$0.00B
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$0.97
EPS Est.
-$1.80
EPS Surpr.
+46.1%
Revenue
$0.00B
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.06
EPS Surpr.
+83.3%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$0.06
EPS Est.
-$0.15
EPS Surpr.
+60.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-1.80 | $-1.80 | $-1.80 | 1 |
| Q3 FY2025 | $-1.80 | $-1.80 | $-1.80 | 1 |
| Q2 FY2025 | $-1.80 | $-1.80 | $-1.80 | 1 |
| Q1 FY2025 | $-1.80 | $-1.80 | $-1.80 | 1 |
| Q4 FY2024 | $-1.80 | $-1.80 | $-1.80 | 1 |
| Q3 FY2024 | $-1.80 | $-1.80 | $-1.80 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | $1.68 | $1.55 | -7.74% |
| ▲ Q1 FY2026 | Mar 13, 2026 | +55.6% | $4.56 | $2.80 | -38.60% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +45.6% | $3.81 | $3.74 | -1.84% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +46.1% | $3.82 | $4.02 | +5.24% |
| ▲ Q2 FY2025 | May 15, 2025 | +46.1% | $4.53 | $4.00 | -11.70% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +83.3% | $13.89 | $13.20 | -4.97% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +60.0% | $10.80 | $9.23 | -14.54% |
| ▲ Q3 FY2024 | Aug 12, 2024 | +45.5% | $13.28 | $13.38 | +0.75% |
Q2 FY2026-7.74%
Report Date
May 15, 2026
EPS Beat/Miss
—
Price Before
$1.68
Price After
$1.55
Q1 FY2026-38.60%
Report Date
Mar 13, 2026
EPS Beat/Miss
+55.6%
Price Before
$4.56
Price After
$2.80
Q4 FY2025-1.84%
Report Date
Nov 12, 2025
EPS Beat/Miss
+45.6%
Price Before
$3.81
Price After
$3.74
Q3 FY2025+5.24%
Report Date
Aug 14, 2025
EPS Beat/Miss
+46.1%
Price Before
$3.82
Price After
$4.02
Q2 FY2025-11.70%
Report Date
May 15, 2025
EPS Beat/Miss
+46.1%
Price Before
$4.53
Price After
$4.00
Q1 FY2025-4.97%
Report Date
Mar 20, 2025
EPS Beat/Miss
+83.3%
Price Before
$13.89
Price After
$13.20
Q4 FY2024-14.54%
Report Date
Nov 13, 2024
EPS Beat/Miss
+60.0%
Price Before
$10.80
Price After
$9.23
Q3 FY2024+0.75%
Report Date
Aug 12, 2024
EPS Beat/Miss
+45.5%
Price Before
$13.28
Price After
$13.38
Avg Beat Reaction-9.38%
Beat Rate7 / 8 quarters
Largest Move-38.60% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDIO ends December
Cardio Diagnostics Holdings, Inc. (CDIO) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.63 (in line with the analyst consensus of —). CDIO has beaten EPS estimates for 7 consecutive quarters. The next CDIO earnings date is expected around September 1, 2026.
Each quarter, investors track CDIO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDIO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDIO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDIO earnings · 4 questionsCardio Diagnostics Holdings, Inc.'s next earnings report is expected around September 1, 2026. CDIO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDIO historically reports after market close (AMC).
CDIO earnings datewhen is CDIO earningsCDIO next earnings datewhen does CDIO report earningsCDIO earnings calendar
▸ Source: FMP · Cardio Diagnostics Holdings, Inc. SEC filings · US GAAP · Cardio Diagnostics Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026